These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 19941477)

  • 1. Design and development of nanovehicle-based delivery systems for preventive or therapeutic supplementation with flavonoids.
    Leonarduzzi G; Testa G; Sottero B; Gamba P; Poli G
    Curr Med Chem; 2010; 17(1):74-95. PubMed ID: 19941477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement strategies for the oral bioavailability of poorly water-soluble flavonoids: An overview.
    Zhao J; Yang J; Xie Y
    Int J Pharm; 2019 Oct; 570():118642. PubMed ID: 31446024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary flavonoids: bioavailability, metabolic effects, and safety.
    Ross JA; Kasum CM
    Annu Rev Nutr; 2002; 22():19-34. PubMed ID: 12055336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the Development of a Cutaneous Flavonoid Delivery System: Advances and Limitations.
    Costa R; Costa Lima SA; Gameiro P; Reis S
    Antioxidants (Basel); 2021 Aug; 10(9):. PubMed ID: 34573007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flavonoids nanoparticles in cancer: Treatment, prevention and clinical prospects.
    Khan H; Ullah H; Martorell M; Valdes SE; Belwal T; Tejada S; Sureda A; Kamal MA
    Semin Cancer Biol; 2021 Feb; 69():200-211. PubMed ID: 31374244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivering flavonoids into solid tumors using nanotechnologies.
    Wang S; Zhang J; Chen M; Wang Y
    Expert Opin Drug Deliv; 2013 Oct; 10(10):1411-28. PubMed ID: 23862581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-nanoemulsifying drug delivery systems of myricetin: Formulation development, characterization, and in vitro and in vivo evaluation.
    Qian J; Meng H; Xin L; Xia M; Shen H; Li G; Xie Y
    Colloids Surf B Biointerfaces; 2017 Dec; 160():101-109. PubMed ID: 28917148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flavonoids nanostructures promising therapeutic efficiencies in colorectal cancer.
    Hassani S; Maghsoudi H; Fattahi F; Malekinejad F; Hajmalek N; Sheikhnia F; Kheradmand F; Fahimirad S; Ghorbanpour M
    Int J Biol Macromol; 2023 Jun; 241():124508. PubMed ID: 37085076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flavonoids: prospective drug candidates.
    Cazarolli LH; Zanatta L; Alberton EH; Figueiredo MS; Folador P; Damazio RG; Pizzolatti MG; Silva FR
    Mini Rev Med Chem; 2008 Nov; 8(13):1429-40. PubMed ID: 18991758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flavonoids and polymer derivatives as CYP3A4 inhibitors for improved oral drug bioavailability.
    Fasinu P; Choonara YE; Khan RA; Du Toit LC; Kumar P; Ndesendo VM; Pillay V
    J Pharm Sci; 2013 Feb; 102(2):541-55. PubMed ID: 23188647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flavonoids, a ubiquitous dietary phenolic subclass, exert extensive in vitro anti-invasive and in vivo anti-metastatic activities.
    Weng CJ; Yen GC
    Cancer Metastasis Rev; 2012 Jun; 31(1-2):323-51. PubMed ID: 22314287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of stabilizing agents on the development of myricetin nanosuspension and its characterization: an in vitro and in vivo evaluation.
    Hong C; Dang Y; Lin G; Yao Y; Li G; Ji G; Shen H; Xie Y
    Int J Pharm; 2014 Dec; 477(1-2):251-60. PubMed ID: 25445518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging novel drug delivery strategies for bioactive flavonol fisetin in biomedicine.
    Mehta P; Pawar A; Mahadik K; Bothiraja C
    Biomed Pharmacother; 2018 Oct; 106():1282-1291. PubMed ID: 30119198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designing of fatty acid-surfactant conjugate based nanomicelles of morin hydrate for simultaneously enhancing anticancer activity and oral bioavailability.
    Jangid AK; Agraval H; Gupta N; Yadav UCS; Sistla R; Pooja D; Kulhari H
    Colloids Surf B Biointerfaces; 2019 Mar; 175():202-211. PubMed ID: 30530006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro biological properties of flavonoid conjugates found in vivo.
    Williamson G; Barron D; Shimoi K; Terao J
    Free Radic Res; 2005 May; 39(5):457-69. PubMed ID: 16036321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preparation of self-emulsifying soft capsule and its pharmacokinetic in rats for epimedium flavonoids].
    Jiang YN; Mo HY
    Zhong Yao Cai; 2010 May; 33(5):767-71. PubMed ID: 20873563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research Progress in Flavonoids as Potential Anticancer Drug Including Synergy with Other Approaches.
    Hussain Y; Luqman S; Meena A
    Curr Top Med Chem; 2020; 20(20):1791-1809. PubMed ID: 32357817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and metabolism of dietary flavonoids in humans.
    Manach C; Donovan JL
    Free Radic Res; 2004 Aug; 38(8):771-85. PubMed ID: 15493450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flavonoids acting on DNA topoisomerases: recent advances and future perspectives in cancer therapy.
    Russo P; Del Bufalo A; Cesario A
    Curr Med Chem; 2012; 19(31):5287-93. PubMed ID: 22998568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.